FORGE NEWS

Business Development Manager Job title: Business Development Manager Location: Remote (UK or Europe-based) Salary: £45,000–£90,000 base salary Contract: Full time Travel: Extensive international travel required Eligibility: Applicants must already have the right to work in the UK or an EU/EEA country About Forge Genetics Forge Genetics is a growing biotechnology company developing microbial genome engineering technologies and providing R&D services to academic and commercial

Bacterial species and strains vary wildly in our ability to manipulate them. Model species such as Escherichia coli and Bacillus subtilis are readily transformable and have a range of genetic tools but more exotic, non-model species can present a whole manner of challenges. This is unfortunate because a multitude of interesting, impactful or useful traits are found within non-model species and full exploitation of these traits requires genetic studies. Non-model species are

Paul brings over 40 years of experience in life sciences, including senior leadership roles at Beecham Pharmaceuticals, Genzyme, and GeneMedix where he led the company’s dual listing on the London and Singapore Stock Exchanges. Forge has grown rapidly since its founding two years ago. We’ve developed and deployed a powerful, novel genetic engineering platform to solve problems for leading pharmaceutical and biotech companies. With Paul’s experience in scaling biotech business

Forge Genetics has raised £2m in equity funding from the Midlands Engine Investment Fund II, through its appointed fund manager Mercia Ventures, with support from the British Business Bank. The investment will allow us to scale our commercial work developing engineered bacterial strains for pharmaceutical and biotechnology companies, while accelerating R&D to adapt Forge Editing for use in mammalian cells. Since launching less than two years ago, we have secured over £2m in c

Forge Genetics, a biotechnology company at the forefront of gene-editing technology, has announced that Barnaby Kent MBA has been appointed to the Forge Genetics Advisory Board. Barnaby has over 25 years of experience across technology and M&A leadership roles. He was previously CEO at Plumtree Group and was COO at LSE:AIM listed Ideagen for over a decade before their acquisition in 2022 for £1 billion. Forge Genetics is a biotechnology start-up focused on revolutionising the

Forge Genetics, a biotechnology company at the forefront of genetic-editing technology, has announced that Patrick Ginty, PhD, RAC (US) has been appointed to the Forge Genetics Advisory Board. Patrick has served in multiple senior roles within the cell and gene industry and has led or supported over 50 clinical trials and contributed to the approval of 7 cell and gene therapy products globally. Patrick also previously served as co-chair of the European Regulatory Committee fo

We are thrilled to announce that we have been shortlisted for Health Tech Innovator of the Year as a part of the Innovation Awards 2024, an event that celebrates the forefront of innovation across various industries. The Innovation Awards, organised by the Technology Supply Chain, have established themselves as a premier platform for highlighting ground-breaking advancements. From manufacturing and engineering to sustainability and technology, these awards celebrate innovatio

We are thrilled to announce the appointment of Dr Sophie Dale-Black as our First Advisor! Sophie is a scientifically trained and commercially driven consultant, advisor and non-executive director who is focused on the success of science and innovation-led businesses across the UK. As a member of the Forge Genetics advisory board, Sophie will play a pivotal role in the ongoing innovation of the company, shaping our long-term strategy, highlighting business opportunities and id

Dr Lisa Thomas is currently a Director at The Pioneer Group, a life science specialist property operator and investment fund. As the Venture Development Partner, she works with early-stage life science companies as a sounding board/coach to refine and help build business plans and guide them to investor readiness. She has over 15 years of hands-on and advisory experience working with start-ups and scaling companies. Her career started with a Regenerative Medicine PhD from Not